Does CISPLATIN Cause Malignant neoplasm progression? 2,004 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,004 reports of Malignant neoplasm progression have been filed in association with CISPLATIN (CISplatin). This represents 4.2% of all adverse event reports for CISPLATIN.
2,004
Reports of Malignant neoplasm progression with CISPLATIN
4.2%
of all CISPLATIN reports
726
Deaths
446
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CISPLATIN?
Of the 2,004 reports, 726 (36.2%) resulted in death, 446 (22.3%) required hospitalization, and 79 (3.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 2,004 reports have been filed with the FAERS database.
What Other Side Effects Does CISPLATIN Cause?
Off label use (4,359)
Disease progression (3,746)
Neutropenia (3,095)
Febrile neutropenia (3,010)
Nausea (2,923)
Drug ineffective (2,608)
Thrombocytopenia (2,565)
Anaemia (2,530)
Vomiting (2,326)
Diarrhoea (2,022)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CISPLATIN Alternatives Have Lower Malignant neoplasm progression Risk?
CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE
CISPLATIN vs CITALOPRAM
CISPLATIN vs CITALOPRAM HYDROBROMIDE
CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE
CISPLATIN vs CITICOLINE